Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production
Identifieur interne : 000243 ( France/Analysis ); précédent : 000242; suivant : 000244Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production
Auteurs : Thomas G. Evans [États-Unis] ; Esper G. Kallas [États-Unis, Brésil] ; Meredith Campbell [États-Unis] ; Jolene Andrews [États-Unis] ; David Schwartz [États-Unis] ; Michael Keefer [États-Unis] ; Pierre Caudrelier [France]Source :
- Immunology Letters [ 0165-2478 ] ; 2001.
English descriptors
- KwdEn :
- Teeft :
- Assay, Autologous, Becton dickinson immunocytometry systems, Blcl, Canarypox, Canarypox immunization, Cell lines, Cell responses, Chromium, Chromium release, Chromium release assay, Chromium release assays, Chromium release techniques, Cytokine, E6ans, Effector, Effector cells, Effector population, Elsevier science, Emmes corporation, Fourth immunization, Fourth vaccination, Gene product, Ifng, Immunization, Immunology, Immunology letters, Infg, Intracellular, Intracellular staining, Isotype, Isotype control, Isotype controls, Lymphocyte gate, Number positi6es, Overall response, Pbmcs, Peptide, Peptide pool, Permeabilization buffer, Positive assay, Positive assays, Rank order, Recombinant, Response rate, Response rates, Rochester aveu, Staining buffer, Tight gates, Unstained sample, Vaccination, Vaccine, Vaccine trial, Vaccinia, Vaccinia control, Vaccinia vectors.
Abstract
Abstract: CD8+ cytolytic activity is traditionally measured by detecting the release of 51Cr after incubation of effector cells with HLA-matched, infected, radiolabeled targets. An alternative method to detect CD8+ activity is to measure the production of intracellular interferon gamma (IFNγ) after antigen-specific stimulation, either by ELISPOT or by flow cytometry. Studies were performed in 19 volunteers enrolled in a phase 1 trial of candidate canarypox HIV-1 vaccines that encoded multiple HIV-1 genes. The vaccines including vCP205 (Env, Gag, and protease), vCP1433 (Env, Gag, protease, and CTL epitope-rich regions of pol and nef) and vCP1452 (equivalent to vCP1433 with additional immunomodulatory genes of vaccinia). PBMCs were stimulated in vitro with vaccinia constructs encoding env and gag or a lacZ control, and the effectors were cultured for 12–14 days. EBV-transformed B cell lines were infected overnight with the vaccinia vectors, and then incubated with the effector cells for 4 h in the presence of monensin. CD8+ gene-specific activity was determined as a percentage of IFNγ cells in the CD3+CD8+CD45RO+ gate after subtracting both the isotype control and the lacZ control stimulation. CD4 memory IFNγ production was simultaneously determined in the CD3+CD8−CD45RO+ gate. Using these techniques in blinded studies, we found that CD8+ IFNγ activity could be measured in the majority of volunteers given four immunizations. Specifically, the responses to the gag gene were control — 0/2; vCP205 — 2/4; vCP1433 — 5/6; vCP1452 — 4/7. Most of the positive responses were detected after the fourth immunization. Flow cytometric techniques hold promise as a surrogate measure of CTL and for ease of phenotyping of the effector population.
Url:
DOI: 10.1016/S0165-2478(01)00173-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000925
- to stream Istex, to step Curation: 000925
- to stream Istex, to step Checkpoint: 000E89
- to stream Main, to step Merge: 003605
- to stream Main, to step Curation: 003567
- to stream Main, to step Exploration: 003567
- to stream France, to step Extraction: 000243
Links to Exploration step
ISTEX:65A64D2B74F2447A5B5798DCB3ED28295022CD77Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production</title>
<author><name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
</author>
<author><name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
</author>
<author><name sortKey="Campbell, Meredith" sort="Campbell, Meredith" uniqKey="Campbell M" first="Meredith" last="Campbell">Meredith Campbell</name>
</author>
<author><name sortKey="Andrews, Jolene" sort="Andrews, Jolene" uniqKey="Andrews J" first="Jolene" last="Andrews">Jolene Andrews</name>
</author>
<author><name sortKey="Schwartz, David" sort="Schwartz, David" uniqKey="Schwartz D" first="David" last="Schwartz">David Schwartz</name>
</author>
<author><name sortKey="Keefer, Michael" sort="Keefer, Michael" uniqKey="Keefer M" first="Michael" last="Keefer">Michael Keefer</name>
</author>
<author><name sortKey="Caudrelier, Pierre" sort="Caudrelier, Pierre" uniqKey="Caudrelier P" first="Pierre" last="Caudrelier">Pierre Caudrelier</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:65A64D2B74F2447A5B5798DCB3ED28295022CD77</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0165-2478(01)00173-0</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-RFRLMXZ5-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000925</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000925</idno>
<idno type="wicri:Area/Istex/Curation">000925</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E89</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E89</idno>
<idno type="wicri:doubleKey">0165-2478:2001:Evans T:evaluation:of:canarypox</idno>
<idno type="wicri:Area/Main/Merge">003605</idno>
<idno type="wicri:Area/Main/Curation">003567</idno>
<idno type="wicri:Area/Main/Exploration">003567</idno>
<idno type="wicri:Area/France/Extraction">000243</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production</title>
<author><name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>1 Present address: Universidade Federal de São Paulo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Campbell, Meredith" sort="Campbell, Meredith" uniqKey="Campbell M" first="Meredith" last="Campbell">Meredith Campbell</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Andrews, Jolene" sort="Andrews, Jolene" uniqKey="Andrews J" first="Jolene" last="Andrews">Jolene Andrews</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwartz, David" sort="Schwartz, David" uniqKey="Schwartz D" first="David" last="Schwartz">David Schwartz</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Johns Hopkins University, Sacramento, CA</wicri:regionArea>
<wicri:noRegion>CA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Keefer, Michael" sort="Keefer, Michael" uniqKey="Keefer M" first="Michael" last="Keefer">Michael Keefer</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Caudrelier, Pierre" sort="Caudrelier, Pierre" uniqKey="Caudrelier P" first="Pierre" last="Caudrelier">Pierre Caudrelier</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Aventis Pasteur, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Immunology Letters</title>
<title level="j" type="abbrev">IMLET</title>
<idno type="ISSN">0165-2478</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">77</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="7">7</biblScope>
<biblScope unit="page" to="15">15</biblScope>
</imprint>
<idno type="ISSN">0165-2478</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0165-2478</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Canarypox-induced CD8+ responses</term>
<term>Effector population</term>
<term>IFNγ production</term>
<term>Immunization</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Assay</term>
<term>Autologous</term>
<term>Becton dickinson immunocytometry systems</term>
<term>Blcl</term>
<term>Canarypox</term>
<term>Canarypox immunization</term>
<term>Cell lines</term>
<term>Cell responses</term>
<term>Chromium</term>
<term>Chromium release</term>
<term>Chromium release assay</term>
<term>Chromium release assays</term>
<term>Chromium release techniques</term>
<term>Cytokine</term>
<term>E6ans</term>
<term>Effector</term>
<term>Effector cells</term>
<term>Effector population</term>
<term>Elsevier science</term>
<term>Emmes corporation</term>
<term>Fourth immunization</term>
<term>Fourth vaccination</term>
<term>Gene product</term>
<term>Ifng</term>
<term>Immunization</term>
<term>Immunology</term>
<term>Immunology letters</term>
<term>Infg</term>
<term>Intracellular</term>
<term>Intracellular staining</term>
<term>Isotype</term>
<term>Isotype control</term>
<term>Isotype controls</term>
<term>Lymphocyte gate</term>
<term>Number positi6es</term>
<term>Overall response</term>
<term>Pbmcs</term>
<term>Peptide</term>
<term>Peptide pool</term>
<term>Permeabilization buffer</term>
<term>Positive assay</term>
<term>Positive assays</term>
<term>Rank order</term>
<term>Recombinant</term>
<term>Response rate</term>
<term>Response rates</term>
<term>Rochester aveu</term>
<term>Staining buffer</term>
<term>Tight gates</term>
<term>Unstained sample</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Vaccine trial</term>
<term>Vaccinia</term>
<term>Vaccinia control</term>
<term>Vaccinia vectors</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: CD8+ cytolytic activity is traditionally measured by detecting the release of 51Cr after incubation of effector cells with HLA-matched, infected, radiolabeled targets. An alternative method to detect CD8+ activity is to measure the production of intracellular interferon gamma (IFNγ) after antigen-specific stimulation, either by ELISPOT or by flow cytometry. Studies were performed in 19 volunteers enrolled in a phase 1 trial of candidate canarypox HIV-1 vaccines that encoded multiple HIV-1 genes. The vaccines including vCP205 (Env, Gag, and protease), vCP1433 (Env, Gag, protease, and CTL epitope-rich regions of pol and nef) and vCP1452 (equivalent to vCP1433 with additional immunomodulatory genes of vaccinia). PBMCs were stimulated in vitro with vaccinia constructs encoding env and gag or a lacZ control, and the effectors were cultured for 12–14 days. EBV-transformed B cell lines were infected overnight with the vaccinia vectors, and then incubated with the effector cells for 4 h in the presence of monensin. CD8+ gene-specific activity was determined as a percentage of IFNγ cells in the CD3+CD8+CD45RO+ gate after subtracting both the isotype control and the lacZ control stimulation. CD4 memory IFNγ production was simultaneously determined in the CD3+CD8−CD45RO+ gate. Using these techniques in blinded studies, we found that CD8+ IFNγ activity could be measured in the majority of volunteers given four immunizations. Specifically, the responses to the gag gene were control — 0/2; vCP205 — 2/4; vCP1433 — 5/6; vCP1452 — 4/7. Most of the positive responses were detected after the fourth immunization. Flow cytometric techniques hold promise as a surrogate measure of CTL and for ease of phenotyping of the effector population.</div>
</front>
</TEI>
<affiliations><list><country><li>Brésil</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Lyon</li>
</settlement>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
</noRegion>
<name sortKey="Andrews, Jolene" sort="Andrews, Jolene" uniqKey="Andrews J" first="Jolene" last="Andrews">Jolene Andrews</name>
<name sortKey="Campbell, Meredith" sort="Campbell, Meredith" uniqKey="Campbell M" first="Meredith" last="Campbell">Meredith Campbell</name>
<name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
<name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
<name sortKey="Keefer, Michael" sort="Keefer, Michael" uniqKey="Keefer M" first="Michael" last="Keefer">Michael Keefer</name>
<name sortKey="Schwartz, David" sort="Schwartz, David" uniqKey="Schwartz D" first="David" last="Schwartz">David Schwartz</name>
</country>
<country name="Brésil"><noRegion><name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
</noRegion>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Caudrelier, Pierre" sort="Caudrelier, Pierre" uniqKey="Caudrelier P" first="Pierre" last="Caudrelier">Pierre Caudrelier</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000243 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000243 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= France |étape= Analysis |type= RBID |clé= ISTEX:65A64D2B74F2447A5B5798DCB3ED28295022CD77 |texte= Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production }}
This area was generated with Dilib version V0.6.33. |